ScienceEU-Startupsabout 2 hours ago
Revier Therapeutics launches with €6 million seed
3 min read
Revier Therapeutics launched in Heidelberg with €6 million in Seed financing led by KHAN Technology Transfer Fund II, with High-Tech Gründerfonds, VORNvc, and private investors. The biotech develops disease-modifying therapies for cardiometabolic disease, led by CEO Prof. Eva van Rooij.
Level
Hype check
Tap to vote and see what everyone thinks.
Summary by ByteBrief
